Text Size

Noninvasive Optical Measurement of Critical Care Neonates

This study has been completed.
Sponsor:
Collaborator:
Children’s Hospital of Orange County
Information provided by (Responsible Party):
Montana Compton, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT01483703
First received: November 29, 2011
Last updated: January 7, 2013
Last verified: January 2013
History of Changes
  Purpose

The purpose of this study is to determine whether reflections of light can be used to provide real-time pictures of blood vessel formation around infants' heads. This approach is called laser speckle imaging (LSI) developed at UCI Beckman Laser Institute.


Condition Intervention
Neonatal Disorder
 Device: Laser Speckle Imaging (LSI)

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Noninvasive Optical Measurement of Critical Care Neonates

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of California, Irvine:

Primary Outcome Measures:
  • Noninvasive Optical Measurement of Critical Care Neonates [ Time Frame: up to 12 months ] [ Designated as safety issue: No ]

Enrollment: 6
Study Start Date: May 2010
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
diagnostic device
Laser Speckle Imaging (LSI)
 Device: Laser Speckle Imaging (LSI)
LSI
Other Name: Laser Speckle Imaging (LSI)

Detailed Description:

The researchers can use the LSI device to image superficial cerebral blood flow in the infant's head. The researchers can quantify blood flow and measured vessel diameter, versus actual diameter assessed with conventional digital camera imaging.

  Eligibility

Ages Eligible for Study:   up to 6 Weeks
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Children

Criteria

Inclusion Criteria:

  • New born or infant

Exclusion Criteria:

  • non- new born or infant
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01483703

Locations
United States, California
CHOC
Orange, California, United States, 92868
Sponsors and Collaborators
Montana Compton
Children’s Hospital of Orange County
Investigators
Principal Investigator: Bernard Choi, PhD Beckman Laser Institute, UCI
  More Information

No publications provided

Responsible Party: Montana Compton, Adminstrative Research Nurse Coordinator, University of California, Irvine
ClinicalTrials.gov Identifier: NCT01483703     History of Changes
Other Study ID Numbers: LAMMP WIFI
Study First Received: November 29, 2011
Last Updated: January 7, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Infant, Newborn, Diseases

ClinicalTrials.gov processed this record on May 19, 2013